We worked with testers, whose identities we have verified, to test the products and services mentioned in this story. Due to ...

The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight loss medication another option. The new pill, called Foundayo, is made by ...

Being overweight can sometimes impact your mental and physical health, which may lead you to look for healthy weight loss paths. But with so many options out there, it can be confusing to know which ...

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its ...

The program integrates primary care, pharmacy and virtual services to provide coordinated, longitudinal obesity treatment.

Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral ...

Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss ...

Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on ...

Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ...

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...